Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK.
Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
Diabetologia. 2021 Sep;64(9):1963-1972. doi: 10.1007/s00125-021-05484-6. Epub 2021 Jun 10.
AIMS/HYPOTHESIS: People with obesity and a normal metabolic profile are sometimes referred to as having 'metabolically healthy obesity' (MHO). However, whether this group of individuals are actually 'healthy' is uncertain. This study aims to examine the associations of MHO with a wide range of obesity-related outcomes.
This is a population-based prospective cohort study of 381,363 UK Biobank participants with a median follow-up of 11.2 years. MHO was defined as having a BMI ≥ 30 kg/m and at least four of the six metabolically healthy criteria. Outcomes included incident diabetes and incident and fatal atherosclerotic CVD (ASCVD), heart failure (HF) and respiratory diseases.
Compared with people who were not obese at baseline, those with MHO had higher incident HF (HR 1.60; 95% CI 1.45, 1.75) and respiratory disease (HR 1.20; 95% CI 1.16, 1.25) rates, but not higher ASCVD. The associations of MHO were generally weaker for fatal outcomes and only significant for all-cause (HR 1.12; 95% CI 1.04, 1.21) and HF mortality rates (HR 1.44; 95% CI 1.09, 1.89). However, when compared with people who were metabolically healthy without obesity, participants with MHO had higher rates of incident diabetes (HR 4.32; 95% CI 3.83, 4.89), ASCVD (HR 1.18; 95% CI 1.10, 1.27), HF (HR 1.76; 95% CI 1.61, 1.92), respiratory diseases (HR 1.28; 95% CI 1.24, 1.33) and all-cause mortality (HR 1.22; 95% CI 1.14, 1.31). The results with a 5 year landmark analysis were similar.
CONCLUSIONS/INTERPRETATION: Weight management should be recommended to all people with obesity, irrespective of their metabolic status, to lower risk of diabetes, ASCVD, HF and respiratory diseases. The term 'MHO' should be avoided as it is misleading and different strategies for risk stratification should be explored.
目的/假设:有些人肥胖但代谢状况正常,有时被称为“代谢健康型肥胖”(MHO)。然而,这类人群是否真的“健康”还不确定。本研究旨在探讨 MHO 与多种肥胖相关结局的关联。
这是一项基于人群的前瞻性队列研究,共纳入 381363 名英国生物库参与者,中位随访时间为 11.2 年。MHO 的定义为 BMI≥30kg/m2,且至少符合六项代谢健康标准中的四项。结局包括新发糖尿病以及新发和致死性动脉粥样硬化性心血管疾病(ASCVD)、心力衰竭(HF)和呼吸系统疾病。
与基线时不肥胖的人群相比,MHO 人群的 HF(HR 1.60;95%CI 1.45,1.75)和呼吸系统疾病(HR 1.20;95%CI 1.16,1.25)发生率更高,但 ASCVD 发生率并无差异。MHO 与致死性结局的关联通常较弱,仅在全因(HR 1.12;95%CI 1.04,1.21)和 HF 死亡率(HR 1.44;95%CI 1.09,1.89)方面有统计学意义。然而,与代谢健康但不肥胖的人群相比,MHO 人群的新发糖尿病(HR 4.32;95%CI 3.83,4.89)、ASCVD(HR 1.18;95%CI 1.10,1.27)、HF(HR 1.76;95%CI 1.61,1.92)、呼吸系统疾病(HR 1.28;95%CI 1.24,1.33)和全因死亡率(HR 1.22;95%CI 1.14,1.31)发生率更高。采用 5 年时间节点分析的结果相似。
结论/解释:不论代谢状态如何,所有肥胖人群均应进行体重管理,以降低糖尿病、ASCVD、HF 和呼吸系统疾病的风险。应避免使用“MHO”这一术语,因为它具有误导性,应探索不同的风险分层策略。